EUVIMEDEUVIMED entdecken
Crossref

QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost

Shehab Fareed Mohamed, Yaser Mahfouz, Anas Hamad, Mohamed Yassin, Deena F Mudawi, Abdulrahman F Al-Mashdali, Maria Alkhadra, Sara Al Dali, Greeshma Joseph, Hannan Zadeh, Sindu Sindu Stanley, Honar Cherif

Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)

DOI: 10.6004/jnccn.2025.7446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Shehab Fareed Mohamed und 11 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Hematology and Bone Marrow Transplant, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1Department of Hematology and Bone Marrow Transplant, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • 2Department of Pharmacy, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • 3Department of Quality and Patient Safety, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • 4Department of Nursing, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Zitieren

APA

Mohamed, S. F., Mahfouz, Y., Hamad, A., Yassin, M., Mudawi, D. F., Al-Mashdali, A. F., Alkhadra, M., Dali, S. A., Joseph, G., Zadeh, H., Stanley, S. S., & Cherif, H. (2026). QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7446

Vancouver

Mohamed SF, Mahfouz Y, Hamad A, Yassin M, Mudawi DF, Al-Mashdali AF, et al. QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7446

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Shehab Fareed and Mahfouz, Yaser and Hamad, Anas and Yassin, Mohamed and Mudawi, Deena F and Al-Mashdali, Abdulrahman F and Alkhadra, Maria and Dali, Sara Al and Joseph, Greeshma and Zadeh, Hannan and Stanley, Sindu Sindu and Cherif, Honar},
  title = {QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {3.5},
  doi = {10.6004/jnccn.2025.7446}
}
Kostenlos starten →